Glazer Walter P. Jr.'s Form 4/A amendment
AmendedEscalade IncESCA · filed Mar 7, 2022
- Accession no.
- 0001415889-22-002670
- Filed
- Mar 7, 2022
- Trade date
- Mar 2-4, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Mar 4, 2022
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market purchases total $65.9K. It was filed 5 days after the trade.
This amendment replaces 0001415889-22-002564 (filed Mar 4, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Glazer Walter P. Jr.CIK 0001640328 | Director, Officer (CEO & PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2022 | Common Stock | MOption exerciseAcquired | +2,500 | –F1 | – | 284,297 | Direct | |
| Mar 4, 2022 | Common Stock | MOption exerciseAcquired | +1,666 | –F1 | – | 285,963 | Direct | |
| Mar 4, 2022 | Common Stock | PPurchaseAcquired | +3,312 | $13.13F2 | +$43,486.56 | 289,275 | Direct | |
| Mar 3, 2022 | Common Stock | PPurchaseAcquired | +1,688 | $13.29F3 | +$22,433.52 | 290,963 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2022 | Common Stock | AGrant or awardAcquired | +75,000 | $0.00 | $0 | 75,000 | Direct | |
| Mar 4, 2022 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 0 | Direct | |
| Mar 4, 2022 | Common Stock | MOption exerciseDisposed | −1,666 | $0.00 | $0 | 1,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted Stock Units (RSUs) converted into common stock on a one-for-one basis.
Referenced by the price of 2 transactions in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $12.97 to $13.44. The price reported reflects the weighted average purchase price. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $13.20 to $13.30. The price reported reflects the weighted average purchase price. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
Each RSU represents a right to receive one share of Escalade common stock pursuant to the Escalade, Incorporated 2017 Incentive Plan (Escalade 2017 Plan).
- F5
On March 2, 2022, the reporting person was granted 75,000 RSUs pursuant to the Escalade 2017 Plan, of which one third will vest on March 2, 2023, one third on March 2, 2024 and one third on March 2, 2025, provided that the reporting person remains an officer of Escalade.
- F6
On March 4, 2020, the reporting person was granted 5,000 RSUs pursuant to the Escalade 2017 Plan, of which 2,500 RSUs vested and settled on March 4, 2021. The remaining 2,500 RSUs vested and settled on March 4, 2022, as reported on this Form 4. All RSUs settle in shares of ESCA common stock.
- F7
On March 4, 2021, the reporting person was granted 3,333 RSUs pursuant to the Escalade 2017 Plan, of which 1,666 RSUs vested and settled on March 4, 2022, as reported in this Form 4. The remaining 1,667 RSUs will vest and settle on March 4, 2023, provided that the reporting person remains a director of Escalade as of such vesting date. All RSUs settle in shares of ESCA common stock.
Remarks
This amendment is filed(1) to report the 3/3/22 open market purchases of shares which information was inadvertently omitted from the original filing, and (2) to correct the number of RSUs granted to the reporting person on 3/2/22 and other information and the footnote relating thereto.